Finanzen von Sabra Health Care REIT Inc (SBRA)SBRASabra Health Care REIT Inc

Evaluating the bottom line, Sabra Health Care REIT, Inc. maintains a gross margin of 62.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -13.59%, while the net margin is -10.70%. These profitability ratios, combined with a Return on Equity (ROE) of 2.40%, provide a clear picture of how effectively SBRA converts its operational activities into shareholder value.

In the context of the broader market, SBRA competes directly with industry leaders such as OUT and PECO. With a market capitalization of $5.19B, it holds a significant position in the sector. When comparing efficiency, SBRA's gross margin of 62.43% stands against OUT's 45.82% and PECO's 71.01%. Such benchmarking helps identify whether Sabra Health Care REIT, Inc. is trading at a premium or discount relative to its financial performance.

Sabra Health Care has shown a steady increase in total revenue, reaching $235.87 million in Q2 2026, up from $221.75 million in Q1 2026. However, the net income for Q2 2026 was a loss of $25.20 million, which raises concerns about profitability. The gross margin has been declining, currently at 62.43%, indicating potential cost pressures.